Heart failure & cardiomyopathies

The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease

J Am Coll CardiolPublished Simulation study of Medicare Part D plans

Authors' conclusion

The IRA will reduce Medicare beneficiaries' out-of-pocket drug costs for the selected cardiovascular conditions by 8% to 87%.

Study context

Population
Medicare Part D beneficiaries with severe hypercholesterolemia, heart failure with reduced ejection fraction (HFrEF), HFrEF with atrial fibrillation (AF), or cardiac transthyretin amyloidosis
Participants
4,137 Part D plans
Comparison
Projected out-of-pocket costs under Inflation Reduction Act (IRA) provisions vs 2022 baseline
Outcome
Projected annual out-of-pocket drug costs per condition
Methodological detailsnationwide
  • Nationwide

Main finding

As reported in the abstract

Mean projected annual out-of-pocket costs
GroupSevere hypercholesterolemiaHFrEFHFrEF with AFAmyloidosisHypercholesterolemiaCardiac transthyretin amyloidosis
2022$1,629$2,758$3,259$14,978
2024$2,855 (12% reduction)$3,468 (77% reduction)
2025$1,954 (29% reduction)$2,000 (39% reduction)$1,491 (8% reduction)$2,000 (87% reduction)

Severe hypercholesterolemia

2022$1,629
2024— not stated in the abstract
2025— not stated in the abstract

HFrEF

2022$2,758
2024— not stated in the abstract
2025$1,954 (29% reduction)

HFrEF with AF

2022$3,259
2024$2,855 (12% reduction)
2025$2,000 (39% reduction)

Amyloidosis

2022$14,978
2024$3,468 (77% reduction)
2025— not stated in the abstract

Hypercholesterolemia

2022— not stated in the abstract
2024— not stated in the abstract
2025$1,491 (8% reduction)

Cardiac transthyretin amyloidosis

2022— not stated in the abstract
2024— not stated in the abstract
2025$2,000 (87% reduction)

Original publication

The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease. J Am Coll Cardiol. Published 30 May 2023. doi:10.1016/j.jacc.2023.03.414

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.